1. Home
  2. PYN vs MRNS Comparison

PYN vs MRNS Comparison

Compare PYN & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYN
  • MRNS
  • Stock Information
  • Founded
  • PYN 2002
  • MRNS 2003
  • Country
  • PYN United States
  • MRNS United States
  • Employees
  • PYN N/A
  • MRNS N/A
  • Industry
  • PYN Investment Managers
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PYN Finance
  • MRNS Health Care
  • Exchange
  • PYN Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • PYN 33.5M
  • MRNS 29.9M
  • IPO Year
  • PYN N/A
  • MRNS 2014
  • Fundamental
  • Price
  • PYN $5.78
  • MRNS N/A
  • Analyst Decision
  • PYN
  • MRNS Buy
  • Analyst Count
  • PYN 0
  • MRNS 12
  • Target Price
  • PYN N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • PYN 19.9K
  • MRNS 1.2M
  • Earning Date
  • PYN 01-01-0001
  • MRNS 03-04-2025
  • Dividend Yield
  • PYN 5.07%
  • MRNS N/A
  • EPS Growth
  • PYN N/A
  • MRNS N/A
  • EPS
  • PYN N/A
  • MRNS N/A
  • Revenue
  • PYN N/A
  • MRNS $31,466,000.00
  • Revenue This Year
  • PYN N/A
  • MRNS $14.97
  • Revenue Next Year
  • PYN N/A
  • MRNS $57.65
  • P/E Ratio
  • PYN N/A
  • MRNS N/A
  • Revenue Growth
  • PYN N/A
  • MRNS 1.63
  • 52 Week Low
  • PYN $4.84
  • MRNS $0.22
  • 52 Week High
  • PYN $6.60
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • PYN 49.82
  • MRNS 8.78
  • Support Level
  • PYN $5.68
  • MRNS $0.54
  • Resistance Level
  • PYN $5.89
  • MRNS $0.55
  • Average True Range (ATR)
  • PYN 0.05
  • MRNS 0.00
  • MACD
  • PYN 0.01
  • MRNS -0.06
  • Stochastic Oscillator
  • PYN 47.19
  • MRNS 0.00

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: